Clinical trials
Terminated Diabetes Mellitus, Type 2 trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 4 |
| 2005 | 3 |
| 2007 | 1 |
| 2009 | 1 |
| 2017 | 3 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 7 |
| Novartis Pharmaceuticals | 2 |
| GlaxoSmithKline | 1 |
| Lexicon Pharmaceuticals | 1 |
| Norwegian University of Science and Technology | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 13 |
| Heart Failure | 2 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus | 1 |
| Hyperglycemia | 1 |
| Hypertension | 1 |
| Obesity | 1 |
| Renal Insufficiency | 1 |
| Renal Insufficiency, Chronic | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.